Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Mild Cognitive Impairment

Significant cognition improvement through BrainXpert Energy Complex

    • Market & Medicine
    • Neurology
    • RX
    • Studies
  • 3 minute read

Patients with Mild Cognitive Impairment (MCI) benefit from taking BrainXpert Energy Complex twice daily. A six-month study proved that the special ketonic drink is an effective alternative source of energy for the brain. For the first time, MCI can now be treated specifically.

15-20% of people over 65 suffer from a decline in cognitive function (MCI), which is considered a transitional stage between normal aging and dementia. The cognitive impairments may result from, among other things, less glucose being available to the brain as an energy source. Symptoms such as memory loss, forgetfulness, and a decrease in decision-making ability and judgment can result.

In the six-month BENEFIC (Brain ENErgy, Functional Imaging and Cognition) randomized controlled trial, the University of Sherbrooke, Canada, investigated the role of ketones in the association with MCI. The question was whether ketones could be used by the brain as an alternative energy source to glucose. For this purpose, a special ketonic drink containing a compound of ketogenic medium-chain triglycerides (kMCT) and milk protein was administered twice daily.

For this purpose, 82 individuals with MCI were randomized in a 1:1 ratio to an intervention group and a placebo group. The intervention group received the ketogenic drink in a serving of 30 g/day kMCT, which increased blood ketones (acetoacetate [AcAc] and beta-hydroxybutyrate [BHB]). The placebo drink provided an equivalent amount of energy that did not produce ketones. Both drinks were taken twice daily for six months. Cognitive function was measured at baseline and after six months of study. Episodic memory was evaluated using the French version of the Free and Cued Selective Reminding Test (FCSRT) and the Brief Visual Memory Test-Revised (BVMT-R). For executive functions, attention, and processing speed, the Trail-Making Test, the Stroop Color and Word Interference Test (Stroop), and the Verbal Fluency Test (VF) from the Delis-Kaplan Executive Function System were used, respectively. The Boston Naming Test (TNT) was used to assess language ability.

Ketones can replace glucose

The study results confirmed that taking BrainXpert Energy Complex clinically showed a doubling of ketones consumed by the brain, significantly reducing the brain energy deficit caused by impaired glucose metabolism. Participants also showed a statistically significant reduction in MCI symptoms: they had improved memory, improved word recall, were able to think faster, and were better able to perform multiple tasks simultaneously compared to participants given the placebo drink.

However, this breakthrough in MCI therapy is said to be just the beginning, as study leader Prof. Stephen Cunnane shared, ” The finding of significant improvement in cognitive function in patients with MCI is an exciting development that greatly motivates us to stay on this research path. This is just the beginning, and the hope is that new innovations can be found that not only improve brain function, but also slow the progression of Alzheimer’s disease and other age-related forms of cognitive decline. These results should significantly improve the quality of life for people with MCI.”

BrainXpert, a food for special medical purposes, is a ketonic drink for the treatment of patients with mild cognitive impairment and will be launched in Switzerland in the fall of 2021.

Source: “New Study: BrainXpert Energy Complex Shows Significant Improvement in Cognitive Function in Patients with Mild Cognitive Impairment (MCI),” 4. November 2020, Nestle HealthScience

  • Nestle Health Science

 

Further reading:

  • Fortier M, et al: A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment Alzheimer’s & Dementia 2019;15: 625-634.
  • Fortier M, et al: A ketogenic drink improves cognition in Mild Cognitive Impairment: results of a 6-month RCT. In press Alzheimer’s & Dementia 2020

 

InFo NEUROLOGY & PSYCHIATRY 2021; 19(1): 38.

Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Previous Article
  • Chronic constipation

How laxatives get digestion moving again

  • Education
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • RX
View Post
Next Article
  • Skin cancer: epidemiological development

Marked increase in incidence predicted

  • Congress Reports
  • Dermatology and venereology
  • Oncology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.